Loading clinical trials...

Precision Assignment of Intervention Messages to Promote Physical Activity - Precision AIM | Clinical Trials | Clareo Health

UNKNOWNPHASE1/PHASE2

Precision Assignment of Intervention Messages to Promote Physical Activity - Precision AIM

Phase 1 Clinical Trial to Develop a Personalized Adaptive Text Message Intervention Using Control Systems Engineering Tools to Increase Physical Activity in Early Adulthood

NCT04972279•Penn State University

View on ClinicalTrials.gov

Summary

Our goal is to develop personalized decision rules for selecting the frequency, timing, and content of messages to promote physical activity. The objective of this project is to evaluate the acceptability and feasibility of two strategies for calibrating decision rules used to send those messages. Participants will wear an activity monitor for the collection of PA data and be randomly assigned to one of two adaptive intervention strategies. The decision rule for each participant will be refined on a monthly basis throughout the 6-month study based upon the accumulating data on how each participant is responding to different messages under different conditions. Our hypothesis is that more intensive intervention strategies will offer a better user experience because the resulting treatments will be experienced as more personalized.

Eligibility

Age

18 - 29 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Participants capable of reading, speaking and understanding English and of giving informed consent.
•Participants between the ages of 18-29 years.
•Participants must be free of visual impairment that would interfere with the receipt of text messages on their phone.
•Participants must be willing to wear a Fitbit Versa 3 almost continually (23.5 hours/day) for a 6- month period of time.
•Participants must own an iPhone or Android smartphone that they would be willing to download the custom Precision AIM and Fitbit app onto and sync with a Fitbit Versa 3.
•Participants interested in setting goals to increase their physical activity levels over the 6-month study.

Exclusion Criteria

•Participants engaging in 150 or more minutes of moderate- or greater intensity PA /week as assessed by a research grade accelerometer.
•Participants engaged in organized programs with mandated physical activity (e.g., varsity sports, ROTC).
•Participants with contraindications to normal physical activity on the Physical Activity Readiness Questionnaire.
•Participants who require an assistive device for mobility or have any other condition that may limit or prevent participation in moderate-intensity physical activity.
•Participants who are pregnant or planning to become pregnant within the next 6 months.
•Participants with a prior diagnosis of cancer, cardiovascular disease, diabetes or metabolic syndrome.

Locations (1)

The Pennsylvania State University

University Park, Pennsylvania, United States

Key Dates

Start Date

January 2, 2022

Primary Completion Date

December 15, 2022

Completion Date

December 15, 2022

Last Updated

August 10, 2022

Enrollment

ACTUAL participants

Conditions

Cardiovascular Risk Factor

Interventions

Digital message (text + image)

BEHAVIORAL

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

NCT06225544

HaemodialysisChronic Kidney Disease Requiring Chronic Dialysis+3 more

View study

RECRUITING

Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)

NCT04388943

Cardiovascular DiseasesCardiovascular Risk Factor

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 10, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Precision Assignment of Intervention Messages to Promote Physical Activity - Precision AIM

Inclusion Criteria

Exclusion Criteria

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)

Body Weight, Sleep, and Heart Health

MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway

Southampton Women's Survey

The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort